[1]
“The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature”, Reumatismo, vol. 70, no. 2, pp. 78–84, Jul. 2018, doi: 10.4081/reumatismo.2018.1011.